Cargando…
Mesenchymal Stem Cells and Cardiovascular Disease: A Bench to Bedside Roadmap
In recent years, the incredible boost in stem cell research has kindled the expectations of both patients and physicians. Mesenchymal progenitors, owing to their availability, ease of manipulation, and therapeutic potential, have become one of the most attractive options for the treatment of a wide...
Autores principales: | Mazo, Manuel, Araña, Miriam, Pelacho, Beatriz, Prosper, Felipe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270473/ https://www.ncbi.nlm.nih.gov/pubmed/22315617 http://dx.doi.org/10.1155/2012/175979 |
Ejemplares similares
-
Allogeneic Mesenchymal Stem Cells and Biomaterials: The Perfect Match for Cardiac Repair?
por: Perez-Estenaga, Inigo, et al.
Publicado: (2018) -
Mesenchymal stem cells and connective tissue diseases: From bench to bedside
por: Shi, Yue, et al.
Publicado: (2022) -
Mast Cells in Cardiovascular Disease: From Bench to Bedside
por: Hermans, M. A. W., et al.
Publicado: (2019) -
Micrornas and Cardiovascular Diseases: From Bench to Bedside
por: De Rosa, R., et al.
Publicado: (2018) -
Mesenchymal stem cells for subchondral bone marrow lesions: From bench to bedside
por: Pasculli, Rosa M., et al.
Publicado: (2022)